In addition, given that mirodenafil increases cGMP by inhibiting PDE5, we also assumed that the cGMP-PDE5 pathway may play an important role in the fibrotic process in the pathogenesis of SSc. This evidence concerns the gene PDE5A and systemic sclerosis.